Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
BBU
Brookfield Business Partners L.P.
Healthscope operates hospital services, a healthcare services/ facilities business.
|
$2.61B |
$35.38
+0.67%
|
|
SPNT
SiriusPoint Ltd.
Accident & Health lines indicate health-related insurance offerings, aligned with Health Insurance.
|
$2.61B |
$21.88
-1.97%
|
|
ATS
ATS Corporation
ATS-related offerings intersect with Medical Devices & Biometrics via automated production of regulated devices.
|
$2.60B |
$27.79
+3.52%
|
|
BBUC
Brookfield Business Corporation
Operates private hospitals and related hospital services.
|
$2.60B |
$35.68
+0.14%
|
|
WVE
Wave Life Sciences Ltd.
Wave Life Sciences' core products are stereopure oligonucleotides and oligonucleotide therapeutics (antisense/siRNA/editing AIMers) used as RNA medicines.
|
$2.56B |
$16.26
+0.93%
|
|
ITGR
Integer Holdings Corporation
Integer is a contract development and manufacturing organization (CDMO) for medical devices, directly providing design, development and manufacturing services to OEMs.
|
$2.56B |
$74.60
+2.07%
|
|
BHC
Bausch Health Companies Inc.
Xifaxan and the RED-C program are oral small-molecule therapeutics within the Salix hepatology portfolio.
|
$2.56B |
$6.92
+0.14%
|
|
CON
Concentra Group Holdings Parent, Inc.
Concentra operates a nationwide network of outpatient occupational health centers and onsite employer clinics, i.e., outpatient/ASC operations.
|
$2.55B |
$19.66
-1.11%
|
|
DNLI
Denali Therapeutics Inc.
DNL310 and DNL126 are recombinant enzymes delivered via Denali's TransportVehicle platform, representing its core product categories.
|
$2.54B |
$16.95
-2.22%
|
|
EWTX
Edgewise Therapeutics, Inc.
Edgewise's lead programs sevasemten and EDG-7500 are orally administered small-molecule therapeutics, i.e., an oral small molecule therapeutics platform.
|
$2.52B |
$22.76
-4.93%
|
|
OCUL
Ocular Therapeutix, Inc.
ELUTYX is a proprietary drug-delivery platform central to Ocular Therapeutix's retina-focused pipeline.
|
$2.47B |
$14.38
+1.45%
|
|
OLMA
Olema Pharmaceuticals, Inc.
Olema is a biotechnology company focused on oncology therapies, including palazestrant in ER+ breast cancer.
|
$2.46B |
$34.97
-2.40%
|
|
BKD
Brookdale Senior Living Inc.
Brookdale provides healthcare services and facilities through its senior living communities, including care delivery and facility management.
|
$2.45B |
$10.52
+2.09%
|
|
ADPT
Adaptive Biotechnologies Corporation
ADPT directly provides clonoSEQ MRD diagnostic testing and related laboratory services.
|
$2.39B |
$15.92
+1.47%
|
|
MLYS
Mineralys Therapeutics, Inc.
The company is pursuing a cardiovascular hypertension therapy, placing Mineralys under the Cardiovascular Drugs category.
|
$2.39B |
$36.20
+0.51%
|
|
GEO
The GEO Group, Inc.
Provides continuum of care rehabilitation and post-release services as part of corrections/rehabilitation programs.
|
$2.36B |
$16.57
-0.48%
|
|
RCUS
Arcus Biosciences, Inc.
Arcus operates in oncology with innovative IO therapies (HIF-2α inhibitor casdatifan; TIGIT antibody domvanalimab; CD73 inhibitor quemliclustat) making it a Biotech - Oncology company.
|
$2.33B |
$22.18
+1.23%
|
|
EYE
National Vision Holdings, Inc.
Provides eye care services including eye exams across its store network.
|
$2.29B |
$28.40
-1.80%
|
|
PGNY
Progyny, Inc.
Progyny Rx is an integrated pharmacy benefits solution, aligning with PBM-like capabilities for medications within its program.
|
$2.26B |
$26.06
-1.06%
|
|
XRAY
DENTSPLY SIRONA Inc.
XRAY directly manufactures dental equipment used in clinical practice (imaging, CAD/CAM, etc.), fitting this tag.
|
$2.24B |
$11.29
+0.13%
|
|
HRMY
Harmony Biosciences Holdings, Inc.
Harmony's WAKIX and pipeline assets target rare neurological diseases, aligning with Biotech - Rare Diseases.
|
$2.24B |
$39.08
+0.41%
|
|
BBAI
BigBear.ai Holdings, Inc.
VeriScan biometric traveler processing indicates biometrics/biometric sensing offerings.
|
$2.21B |
$5.84
-2.09%
|
|
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Ascentage Pharma is a biotech company focused on oncology, developing apoptosis-targeted cancer therapies (olverembatinib, lisaftoclax, alrizomadlin).
|
$2.17B |
$29.85
+8.15%
|
|
OSW
OneSpaWorld Holdings Limited
Medi-Spa offerings utilize medical devices and biometrics (e.g., CoolSculpting Elite, Elemis Biotec, LightStim).
|
$2.17B |
$21.25
+0.50%
|
|
NHC
National HealthCare Corporation
NHC operates integrated healthcare services and facilities, including skilled nursing, home health, hospice, and behavioral health services.
|
$2.17B |
$138.80
-0.76%
|
|
ETNB
89bio, Inc.
Pegozafermin is a peptide-based therapeutic; directly marketed as a Peptide Therapeutics product.
|
$2.17B |
$14.85
+0.07%
|
|
AORT
Artivion, Inc.
Artivion's core business is manufacturing medical devices and implantable tissues across cardiology and vascular platforms.
|
$2.14B |
$45.98
+1.33%
|
|
ADUS
Addus HomeCare Corporation
Core service line providing Home Health & Hospice care in-home.
|
$2.12B |
$112.98
-1.87%
|
|
SRPT
Sarepta Therapeutics, Inc.
Directly develops gene therapies (ELEVIDYS) and other gene therapy programs; gene therapy is Sarepta's core biotech focus.
|
$2.11B |
$22.35
+3.71%
|
|
IBRX
ImmunityBio, Inc.
Lead oncology-focused biotechnology with ANKTIVA and cancer immunotherapy platforms.
|
$2.10B |
$2.17
-2.03%
|
|
ESTA
Establishment Labs Holdings Inc.
Motiva implants, tissue expanders, and related breast prosthetic devices are the core product line, i.e., prosthetics & implants.
|
$2.09B |
$73.47
+2.00%
|
|
AVDL
Avadel Pharmaceuticals plc
LUMRYZ is an oral small molecule therapeutic (sodium oxybate) used to treat narcolepsy; Avadel's core product.
|
$2.08B |
$21.37
-0.23%
|
|
AUPH
Aurinia Pharmaceuticals Inc.
LUPKYNIS is an oral small-molecule therapeutic, and Aurinia's AUR200 program reflects a focus on oral small-molecule therapeutics in its pipeline.
|
$2.07B |
$15.91
+1.40%
|
|
GLPG
Galapagos N.V.
Strategic focus on oncology cell therapies and cancer indications.
|
$2.05B |
$31.07
-0.14%
|
Showing page 10 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
